Yu Yang
Chongqing Medical University
5 Papers
5 Citations
Yu Yang is an academic researcher from Chongqing Medical University. The author has contributed to research in topics: Ovarian cancer & Carcinogenesis. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Tao Liu,Qinglv Wei,Jing Jin,Qingya Luo,Yi Liu,Yi Liu,Yu Yang,Chunming Cheng,Lanfang Li,Jingnan Pi,Yanmin Si,Hualiang Xiao,Li Li,Shuan Rao,Fang Wang,Jianhua Yu,Jia Yu,Dongling Zou,Ping Yi,Ping Yi +19 more
TL;DR: The novel YTHDF1-EIF3C axis critical for ovarian cancer progression is identified which can serve as a target to develop therapeutics for cancer treatment and modification of Eif3C mRNA is more relevant to its role in cancer.
Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer
Yu Yang,Qinglv Wei,Yuling Tang,Yuanyuan Wang,Qingya Luo,Hongyan Zhao,Min He,Haocheng Wang,Q L Zeng,Weiliang Lu,Jing Xu,Tao Liu,Ping Yi +12 more
TL;DR: It is demonstrated that hnRNPA2B1 facilitates the malignant phenotype of ovarian cancer through activating Lin28B expression and re-expression ofLin28B in hn RNPA2 B1 knockdown cells results in rescued phenotypes.
68
Exploration of the Role of m6 A RNA Methylation Regulators in Malignant Progression and Clinical Prognosis of Ovarian Cancer.
TL;DR: In this paper, a multivariate Cox proportional hazard model was used to screen the key m6A regulators associated with the prognosis of ovarian cancer and the last absolute shrinkage and selection operator (LASSO) Cox regression is used to construct the gene signature for prognosis prediction.
The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ.
Tao Liu,Yu Yang,Zhe Xie,Qingya Luo,Dan Yang,Xiaoyi Liu,Hongyan Zhao,Hongyan Zhao,Qinglv Wei,Yi Liu,Lanfang Li,Yuya Wang,Fang Wang,Jianhua Yu,Jing Xu,Jia Yu,Ping Yi +16 more
TL;DR: Zhang et al. as discussed by the authors reported that the RBP QKI5 was significantly negatively correlated with aggressive tumor stage and worse prognosis in serous ovarian cancer patients.
2
YTHDF1 Aggravates the Progression of Cervical Cancer Through m 6 A-Mediated Up-Regulation of RANBP2.
TL;DR: In this paper, the authors showed that YTHDF1 was highly expressed in cervical cancer, and was closely associated with the poor prognosis of cervical cancer patients, and YDF1 knockdown suppressed the growth, migration and invasion, and induced apoptosis.